KEGG   DISEASE: 神経線維腫症 II 型
エントリ  
H01438                                                             
名称    
神経線維腫症 II 型
概要    
Neurofibromatosis 2 (NF2) is a rare autosomal dominant multiple neoplasia syndrome that is caused by inactivating mutations of the NF2 tumour suppressor gene. The course of the disease is usually progressive, though variable, causing significant morbidity associated with deafness, blindness, brain stem compression, gait instability, and paralysis. Onset typically occurs while a patient is in their 20s. Vestibular schwannomas, usually bilateral, occur in more than 90% of adult patients and intracranial meningiomas occur in about 50% of patients.
カテゴリ  
先天奇形
階層分類  
ICD-11 による疾患分類 [BR:jp08403]
 20 発達異常
  多発性の発達異常または症候群
   LD2D  母斑症または過誤腫性腫瘍性症候群
    H01438  神経線維腫症 II 型
指定難病 [jp08407.html]
 H01438
パスウェイ 
hsa04390  Hippo signaling pathway
hsa04530  Tight junction
病因遺伝子 
NF2 [HSA:4771] [KO:K16684]
リンク   
ICD-11: LD2D.11
MeSH: D016518
OMIM: 101000
文献    
  著者
Evans DG
  タイトル
Neurofibromatosis type 2 (NF2): a clinical and molecular review.
  雑誌
Orphanet J Rare Dis 4:16 (2009)
DOI:10.1186/1750-1172-4-16
文献    
  著者
Baser ME, Kuramoto L, Woods R, Joe H, Friedman JM, Wallace AJ, Ramsden RT, Olschwang S, Bijlsma E, Kalamarides M, Papi L, Kato R, Carroll J, Lazaro C, Joncourt F, Parry DM, Rouleau GA, Evans DG
  タイトル
The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.
  雑誌
J Med Genet 42:540-6 (2005)
DOI:10.1136/jmg.2004.029504
文献    
  著者
Lim SH, Ardern-Holmes S, McCowage G, de Souza P
  タイトル
Systemic therapy in neurofibromatosis type 2.
  雑誌
Cancer Treat Rev 40:857-61 (2014)
DOI:10.1016/j.ctrv.2014.05.004
LinkDB    

» English version

DBGET integrated database retrieval system